研究者詳細 - 寺井　崇二

論文 - 寺井　崇二

分割表示 1,167 件中 501 - 520 件目／全件表示 >>

新潟県における肝炎対策査読

荒生祥尚, 菊田玲, 渡辺和仁, 中山均, 田村務, 薛徹, 寺井崇二

肝臓 61 ( Suppl.1 ) A263 - A263 2020年4月

当院における肝炎医療コーディネーターの取り組みと今後の課題査読

廣川光, 薛徹, 荒生祥尚, 澤栗裕美, 寺井崇二

肝臓 61 ( Suppl.1 ) A246 - A246 2020年4月

Huge liver tumor in young man. 査読国際誌

Osamu Shibata, Kenya Kamimura, Rie Azumi, Kei Shibuya, Shintaro Shiba, Tatsuya Ohno, Shuji Terai

JGH open : an open access journal of gastroenterology and hepatology 4 ( 2 ) 301 - 302 2020年4月

記述言語：英語

Intrahepatic cholangiocarcinoma is the second leading primary hepatic tumors, accounting for 5% of all hepatic tumors. The curability depends on the operability; however, the difficulty of early diagnosis and late clinical presentation account for the poor prognosis. Therefore, development of a novel therapeutic option and a method to determine the viability of the primary tumor, which hinder the assessment of the impact of other therapies, including chemotherapy and radiotherapy are needed. Although FDG-PET has been used to detect distant metastases of ICC, which are present in 20% of patients at the initial diagnosis, little is known about the efficacy of FDG-PET of the primary lesion of ICC. Here, we present the case of a 31-year-old male diagnosed with unresectable ICC and successfully treated with carbon-ion radiation, and present the usefulness of fluorodeoxyglucose-positron emission tomography in the determination of the viability of the tumor.

DOI： 10.1002/jgh3.12234

PubMed

researchmap

Hypereosinophilia-related liver pseudotumor with elevated interleukin-5 levels preceding T-cell lymphoma. 国際誌

Atsunori Tsuchiya, Tomoyuki Tanaka, Yasuhiko Shibasaki, Shuji Terai

JGH open : an open access journal of gastroenterology and hepatology 4 ( 2 ) 312 - 314 2020年4月

記述言語：英語

A 61-year-old woman with hypereosinophilia and elevated interleukin (IL)-5 level was admitted to our hospital after detection of multiple liver tumors. Liver biopsy demonstrated that the tumor consisted of scar tissue with remnants of eosinophilic infiltration, suggesting that it had formed by massive eosinophilic infiltration. The hypereosinophilia was treated mainly by prednisolone, and thereafter, the liver tumors disappeared. However, 10 months postadmission, CD4+ T-cell lymphoma, which can produce IL-5, was detected in the nasopharynx and oropharynx. Therefore, we believe that this is a rare case of hypereosinophilia-related liver pseudotumor induced by presumed by IL-5 elevation.

DOI： 10.1002/jgh3.12253

PubMed

researchmap

自己免疫性肝炎における赤血球容量粒度分布幅変動係数の臨床的意義

高村昌昭, 高綱将史, 薛徹, 上村博輝, 土屋淳紀, 寺井崇二

肝臓 61 ( Suppl.1 ) A433 - A433 2020年4月

肝疾患における移行期医療小児NAFLD患者の背景疾患と移行医療への課題

上村博輝, 上村顕也, 寺井崇二

肝臓 61 ( Suppl.1 ) A142 - A142 2020年4月

肝移植医療における内科・外科連携の現状と問題点本県における急性肝不全に対する肝移植再開に向けた診療ネットワーク運用の検討

薛徹, 寺井崇二

肝臓 61 ( Suppl.1 ) A125 - A125 2020年4月

門脈圧亢進症の診断と治療原発性胆汁性胆管炎における食道静脈瘤発生の検討

薛徹, 横山純二, 寺井崇二

肝臓 61 ( Suppl.1 ) A151 - A151 2020年4月

NAFLDの病態解明及び新規治療法の探索非アルコール性脂肪性肝炎(NASH)モデルマウスを用いたスフィンゴシン1リン酸受容体ブロックによる脂質構成の変化と発癌機構の解明

吉田智彰, 土屋淳紀, 寺井崇二

肝臓 61 ( Suppl.1 ) A215 - A215 2020年4月

肝硬変の予後改善を目指した治療戦略肝硬変に対する間葉系幹細胞由来のエクソソーム療法の開発に向けて

土屋淳紀, 竹内卓, 寺井崇二

肝臓 61 ( Suppl.1 ) A92 - A92 2020年4月

生体試料を用いた研究の最前線間葉系幹細胞のエクソソームによる肝線維化改善抗炎症性マクロファージ誘導法の開発

竹内卓, 土屋淳紀, 寺井崇二

肝臓 61 ( Suppl.1 ) A33 - A33 2020年4月

健診での生活歴から考察したNAFLD症例に対する新しい生活指導法の提案

横尾健, 中野応央樹, 佐藤公俊, 冨永顕太郎, 橋本哲, 高村昌昭, 寺井崇二

肝臓 61 ( Suppl.1 ) A454 - A454 2020年4月

肝発癌進展研究の最前線肝発癌,治療抵抗性にかかわるHHM遺伝子のDNA損傷応答メカニズムの解析

上村顕也, 丹羽佑輔, 寺井崇二

肝臓 61 ( Suppl.1 ) A44 - A44 2020年4月

臓器間ネットワークと肝疾患自律神経経路を介する肝-脳-消化管軸の非アルコール性脂肪肝炎の病態への関与

上村顕也, 大脇崇史, 寺井崇二

肝臓 61 ( Suppl.1 ) A182 - A182 2020年4月

An unusual case of esophageal motility disorder. 査読国際誌

Youhei Koseki, Hiroki Sato, Shuji Terai

Gastroenterology 159 ( 3 ) 838 - 841 2020年3月

Secondary Achalasia in Myotonic Dystrophy May Have a Different Pathology and Management. 査読

Hiroki Sato, Ken-Ichi Mizuno, Satoru Hashimoto, Masafumi Takatsuna, Shuji Terai

Internal medicine (Tokyo, Japan) 59 ( 6 ) 875 - 875 2020年3月

Variations of small bowel transit time on capsule endoscopy 査読国際誌

Tominaga K, Sato H, Yokomichi H, Tsuchiya A, Yoshida T, Kawata Y, Yokoyama J, Terai S

Annals of Translational Medicine in Press ( 6 ) 348 - 348 2020年3月

Rare gastric outlet obstruction owing to ectopic pancreas: a case report and literature review. 国際誌

Kunihiko Yokoyama, Hiroki Sato, Yuichi Sato, Jun Watanabe, Atsuo Nakamura, Shuji Terai

Annals of translational medicine 8 ( 5 ) 252 - 252 2020年3月

記述言語：英語

The ectopic pancreas is often observed in the gastrointestinal tract, and is typically asymptomatic. A 28-year-old woman was referred to our hospital following repeated vomiting after every meal. Following gastroscopy, contrast-enhanced computed tomography (CE-CT), and endoscopic ultrasonography (EUS), she was diagnosed with gastric outlet obstruction, also known as pyloric obstruction, caused by a giant submucosal cystic tumor. The condition was successfully treated with EUS-guided cystic drainage, and she was diagnosed with a cystic tumor originating from the ectopic pancreas. The tumor shrank following EUS-guided cystic drainage, and her obstructive symptoms resolved. In cases with overgrowth of the ectopic pancreas, the differential diagnosis of malignancy is important but challenging. Herein, we report a unique final pathology of this rare case and discuss the findings with a literature review.

DOI： 10.21037/atm.2020.01.64

PubMed

researchmap

Percutaneous Gastrojejunostomy Catheter Placement Using a Slow-Leak Balloon through the Reconstructed Gastric Tube after Esophagectomy. 国際誌

Shinichi Morita, Yasuaki Arai, Shunsuke Sugawara, Miyuki Sone, Koji Tomita, Hiroaki Ishii, Shuji Terai

Journal of vascular and interventional radiology : JVIR 31 ( 3 ) 478 - 481 2020年3月

記述言語：英語掲載種別：研究論文（学術雑誌）

Twelve patients who had undergone esophageal reconstruction because of cancer and in whom conventional percutaneous radiologic or endoscopic gastrostomy was considered difficult are reported. These patients underwent placement of a percutaneous gastrojejunostomy catheter through the reconstructed gastric tube using a slow-leak balloon that had been developed for percutaneous transesophageal gastrotubing. Retrospective evaluation showed successful outcomes without severe complications in all patients. Eight (66.6%) were able to resume oral intake, which allowed gastrojejunostomy catheter withdrawal in 3 (25%). This technique is feasible with acceptable clinical outcomes for patients who have undergone gastric tube reconstruction after esophagectomy.

DOI： 10.1016/j.jvir.2019.09.009

PubMed

researchmap

肝悪性腫瘍との鑑別に苦慮した原発性肝放線菌症の1例

本田博樹, 野澤優次郎, 高村昌昭, 上村博輝, 土屋淳紀, 寺井崇二

肝臓 61 ( 3 ) 109 - 115 2020年3月

　前のページ - 次のページ　

<寺井 崇二>

論文 - 寺井 崇二

<寺井　崇二>

論文 - 寺井　崇二